Praxair Teams Up With Vapotherm - Analyst Blog

By Zacks.com May 11, 2012, 12:07:14 PM EDT

Leading industrial gas supplier Praxair Inc. ( PX ) recently penned a long-term respiratory gas supply contract with Vapotherm, Inc, a primary respiratory care device producer for domestics and hospitals in Stevensville, Maryland.

Under the pact, Praxair and Vapotherm will be jointly engaged in the promotion and supply of the recently introduced heliox system, approved by the U.S. Food and Drug Administration, to the hospitals of North America, Latin America, Spain and Portugal. The heliox system is a high-flow therapy tool which was launched by Vapotherm for uninterrupted supply of helium and oxygen gases through nasal tube.

The Heliox device system will be delivered to the hospitals along with Praxair's heliox gas and a new proprietary gas cart arrangement to ensure security and flexibility of product supply. Additionally, the new system will help the patients take on new non-invasive respiratory option for better recovery.

Furthermore, through the joint venture Praxair is likely to strengthen its client base in the healthcare industry. There is a huge opportunity for the company to grow in  future due to the increased demand for the industrial gases in several sectors. Praxair is estimating that the annual organic sales growth will be 8%-12% by 2015.

Even though, Praxair globally established itself in the diverse markets, it should be aware of the tough competition from its rivals including Kronos Worldwide Inc. ( KRO ) and Cabot Corp. ( CBT ), who are exhibiting striking results.

The current Zacks Consensus Estimates for Praxair is $1.45 and $5.85 for the second quarter of 2012 and for fiscal 2012, respectively. The company currently retains a Zacks #3 Rank, which translates into a short-term 'Hold' rating. We maintain a Neutral recommendation on the stock.


 
CABOT CORP (CBT): Free Stock Analysis Report
 
KRONOS WORLDWD (KRO): Free Stock Analysis Report
 
PRAXAIR INC (PX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Business, Stocks

Referenced Stocks: CBT, KRO, PX



Latest News Video



From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.51 0.08  0.60%
RAD $ 2.80 0.01  0.36%
CSCO $ 23.94 0.30  1.24%
MSFT $ 35.06 0.19  0.54%
WCRX $ 19.60 0.39  2.03%
SIRI $ 3.49 0.01  0.29%
FB $ 25.76 0.49  1.87%
S $ 7.29 0.03  0.41%